McKee Amy E Sells 11,180 Shares of Common Stock in BIOCRYST PHARMACEUTICALS INC

2026-05-19SEC Filing 4 (0000882796-26-000023)

Amy E. McKee, a director at BIOCRYST PHARMACEUTICALS INC (BCRX), reported the sale of 11,180 shares of common stock on May 18, 2026. The shares were sold at a weighted average price of $8.97, with individual transactions ranging from $8.96 to $8.985. Following these transactions, McKee directly owns 31,252 shares of common stock. The weighted average price is detailed in footnote F1, which states that full information regarding the number of shares sold at each price within the specified range will be provided to the SEC upon request. The transaction was reported on Form 4.